Why animal models still matter in drug development: Patient advocates warn that political momentum to reduce animal testing is outpacing the scientific validation of alternative methods.
Patient advocates urge caution on reducing animal research: A patient advocacy group is urging regulators to validate alternative research methods alongside animal models rather than replacing them prematurely, arguing that current non-animal approaches cannot yet replicate the complexity of whole-body responses. The group warned that moving away from animal research too quickly could leave important safety gaps for vulnerable populations, including pregnant women, children, and people with rare diseases.